Medicinal Chemistry of Farnesoid X Receptor (FXR) Modulators: The-State-of-the-Art

被引：0
|
作者：
Marinozzi, Maura [1 ]
机构：
[1] Univ Perugia, Dept Pharmaceut Sci, I-06100 Perugia, Italy
来源：
CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2014年 / 14卷 / 19期
关键词：
D O I：
10.2174/1568026614666141112104841
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：2127 / 2128
页数：2
相关论文
共 50 条
  • [41] Potential therapeutic applications of farcesoid X receptor (FXR) modulators
    Pellicciari, R
    Gioiello, A
    Costantino, G
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (03) : 333 - 341
  • [42] Differential roles of farnesoid X receptor (FXR) in modulating apoptosis in cancer cells
    Girisa, Sosmitha
    Rana, Varsha
    Parama, Dey
    Dutta, Uma
    Kunnumakkara, Ajaikumar B.
    APOPTOSIS IN HEALTH AND DISEASE, PT B, 2021, 126 : 63 - 90
  • [43] a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation
    Renga, Barbara
    Mencarelli, Andrea
    D'Amore, Claudio
    Zampella, Angela
    Distrutti, Eleonora
    Fiorucci, Stefano
    GASTROENTEROLOGY, 2012, 142 (05) : S878 - S878
  • [44] The farnesoid x receptor (FXR) antagonizes oxidized LDL receptor, LOX-1, activation
    Harnish, Douglas
    Hahn, Ashleigh
    Hartman, Helen
    Huard, Christine
    Martinez, Robert
    Mahaney, Paige
    Evans, Mark
    Zhang, Songwen
    CIRCULATION, 2007, 116 (16) : 161 - 161
  • [45] Farnesoid X receptor modulators (2011-2014): a patent review
    Sepe, Valentina
    Distrutti, Eleonora
    Fiorucci, Stefano
    Zampella, Angela
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2015, 25 (08) : 885 - 896
  • [46] Farnesoid X receptor modulators 2014-present: a patent review
    Sepe, Valentina
    Distrutti, Eleonora
    Fiorucci, Stefano
    Zampella, Angela
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2018, 28 (05) : 351 - 364
  • [47] Patented Farnesoid X receptor modulators: a review (2019-present)
    Gioiello, Antimo
    Rosatelli, Emiliano
    Cerra, Bruno
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2024, 34 (07) : 547 - 564
  • [48] Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands
    Carotti, Andrea
    Marinozzi, Maura
    Custodi, Chiara
    Cerra, Bruno
    Pellicciari, Roberto
    Gioiello, Antimo
    Macchiarulo, Antonio
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (19) : 2129 - 2142
  • [49] A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia
    Evans, Mark J.
    Mahaney, Paige E.
    Borges-Marcucci, Lisa
    Lai, KehDih
    Wang, Shuguang
    Krueger, Julie A.
    Gardell, Stephen J.
    Huard, Christine
    Martinez, Robert
    Vlasuk, George P.
    Harnish, Douglas C.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009, 296 (03): : G543 - G552
  • [50] Farnesoid X receptor (FXR): A new marker for the prediction of bone metastases in breast cancer
    Journe, Fabrice
    Durbecq, Virginie
    Chaboteaux, Carole
    Rouas, Ghislane
    Haibe-Kains, Benjamin
    IdBoufker, Hichame
    Laurent, Guy
    Sotiriou, Christos
    Larsimont, Denis
    Body, Jean-Jacques
    CANCER TREATMENT REVIEWS, 2008, 34 : S50 - S50
12345